The Asia-Pacific multiplex assay market is evaluated to register a CAGR of 9.70% during the estimated years of 2021 to 2028. Key factors such as the increasing demand for healthcare infrastructure, the rising healthcare reforms, technological advancements in the field of healthcare, the augmenting research and development sector, and the growing number of hospitals across emerging economies are set to propel the region’s market growth.

ASIA-PACIFIC MULTIPLEX ASSAY MARKET FORECAST 2021-2028

 

Asia Pacific Multiplex Assay Market by Type ( Protein-based Multiplex Assay, Nucleic Acid-based Multiplex Assay, Other Multiplex Assays ) Market by Product ( Reagents and Consumables, Instruments and Accessories, Software and Services ) Market by Technology ( Multiplex Protein Microarray, Multiplex Pcr, Other Technologies ) Market by Application ( Clinical Diagnostics, Research and Development, Companion Diagnostics ) Market by End-user ( Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies ) by Geography.

Request free sample

The Asia-Pacific multiplex assay market is evaluated to register a CAGR of 9.70% during the estimated years of 2021 to 2028. Key factors such as the increasing demand for healthcare infrastructure, the rising healthcare reforms, technological advancements in the field of healthcare, the augmenting research and development sector, and the growing number of hospitals across emerging economies are set to propel the region’s market growth.asia-pacific-multiplex-assay-market

To know more about this report, request a free sample copy.

The Asia-Pacific multiplex assay market growth evaluation entails the assessment of Vietnam, China, India, South Korea, Thailand, Australia & New Zealand, Indonesia, Japan, and the rest of the Asia-Pacific. Biopharmaceuticals in China continue to expand beyond generics in order to focus on the manufacture of more personalized medicine, biomarkers, novel therapies, and multiplex assays. Multiple trends are emerging in China, especially in terms of multiplex assays. The country is one of the several, globally, necessitating patient samples to be used in clinical trials for inclusion within the approval process. Furthermore, according to the valuations of GLOBOCAN, 4,285,033 new cancer cases were predicted in 2018, in addition to 2,865,174 deaths.

On the other hand, in Japan, the multiplex assay market is primarily driven by strategic alliances among key market players to develop multiplex assay tests and government investments to facilitate activities associated with drug development. The demand for multiplex assay in the country is further propelled by the presence of enhanced research and development infrastructure and the increasing incidence of cancer. Thus, these factors are set to reinforce the market growth in the Asia-Pacific over the forecasted period.

Seegene Inc, headquartered in Korea, manufactures molecular diagnostics systems. The company provides in vitro diagnostic reagents for detecting bacteria, viruses, and numerous other disease-causing agents. In addition, it also offers automated magnetic bead-based nucleic acid extractions systems, automatic real-time systems, liquid handling workstations as well as other systems for an accurate diagnosis.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
        • ADOPTION OF PERSONALIZED MEDICINES
      • KEY RESTRAINTS
        • UNAVAILABILITY OF SKILLED LAB TECHNICIANS
        • COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATION
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • KEY BUYING CRITERIA
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY TYPE
      • PROTEIN-BASED MULTIPLEX ASSAY
      • NUCLEIC ACID-BASED MULTIPLEX ASSAY
      • OTHER MULTIPLEX ASSAYS
    3. MARKET BY PRODUCT
      • REAGENTS AND CONSUMABLES
      • INSTRUMENTS AND ACCESSORIES
      • SOFTWARE AND SERVICES
    4. MARKET BY TECHNOLOGY
      • MULTIPLEX PROTEIN MICROARRAY
      • MULTIPLEX PCR
      • OTHER TECHNOLOGIES
    5. MARKET BY APPLICATION
      • CLINICAL DIAGNOSTICS
      • RESEARCH AND DEVELOPMENT
      • COMPANION DIAGNOSTICS
    6. MARKET BY END-USER
      • HOSPITALS
      • CLINICAL LABORATORIES
      • RESEARCH INSTITUTES
      • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    7. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ABCAM
        • AGILENT TECHNOLOGIES INC
        • BECTON, DICKINSON AND COMPANY (BD)
        • BIO-RAD LABORATORIES INC
        • BIO-TECHNE CORPORATION
        • HOFFMANN-LA ROCHE
        • ILLUMINA INC
        • LUMINEX CORPORATION
        • MERCK MILLIPORE
        • OLINK PROTEOMICS AB
        • QIAGEN NV
        • RANDOX LABORATORIES LTD
        • SEEGENE INC
        • SIEMENS HEALTHINEERS AG
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – MULTIPLEX ASSAY

    TABLE 2: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028, (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028, (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028, (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028, (IN $ MILLION)

    TABLE 10: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028, (IN $ MILLION)

    TABLE 12: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: LEADING PLAYERS OPERATING IN THE ASIA-PACIFIC MULTIPLEX ASSAY MARKET

    TABLE 15: LIST OF MERGERS & ACQUISITIONS

    TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020

    FIGURE 6: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)

    FIGURE 7: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)

    FIGURE 8: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020

    FIGURE 10: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)

    FIGURE 12: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)

    FIGURE 13: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 14: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)

    FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)

    FIGURE 17: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

    FIGURE 18: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020

    FIGURE 19: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

    FIGURE 20: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

    FIGURE 21: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)

    FIGURE 22: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020

    FIGURE 23: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

    FIGURE 24: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)

    FIGURE 25: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 26: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

    FIGURE 27: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 28: CHINA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: JAPAN MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: INDIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: THAILAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: INDONESIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: VIETNAM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    1. MARKET BY TYPE
      • PROTEIN-BASED MULTIPLEX ASSAY
      • NUCLEIC ACID-BASED MULTIPLEX ASSAY
      • OTHER MULTIPLEX ASSAYS
    2. MARKET BY PRODUCT
      • REAGENTS AND CONSUMABLES
      • INSTRUMENTS AND ACCESSORIES
      • SOFTWARE AND SERVICES
      • MARKET BY TECHNOLOGY
      • MULTIPLEX PROTEIN MICROARRAY
      • MULTIPLEX PCR
      • OTHER TECHNOLOGIES
    3. MARKET BY APPLICATION
      • CLINICAL DIAGNOSTICS
      • RESEARCH AND DEVELOPMENT
      • COMPANION DIAGNOSTICS
      • MARKET BY END-USER
      • HOSPITALS
      • CLINICAL LABORATORIES
      • RESEARCH INSTITUTES
      • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    4. MARKET BY END-USER
      • HOSPITALS
      • CLINICAL LABORATORIES
      • RESEARCH INSTITUTES
      • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type